1,3-Bis(2,4,6-trimethylphenylimidazolidin-2-ylidene)](tricyclohexylphosphine)-(2-oxobenzylidene)ruthenium(II) chloride
[1,3-Bis(2,4,6-trimethylphenylimidazolidin-2-ylidene)](tricyclohexylphosphine)-(2-oxobenzylidene)ruthenium(II) chloride LatMet
CAS: 1407229-58-6
Molecular Formula: C46H67ClN2OPRu
1,3-Bis(2,4,6-trimethylphenylimidazolidin-2-ylidene)](tricyclohexylphosphine)-(2-oxobenzylidene)ruthenium(II) chloride - Names and Identifiers
1,3-Bis(2,4,6-trimethylphenylimidazolidin-2-ylidene)](tricyclohexylphosphine)-(2-oxobenzylidene)ruthenium(II) chloride - Physico-chemical Properties
| Molecular Formula | C46H67ClN2OPRu |
| Molar Mass | 831.533741 |
| Appearance | Powder |
| Color | green |
1,3-Bis(2,4,6-trimethylphenylimidazolidin-2-ylidene)](tricyclohexylphosphine)-(2-oxobenzylidene)ruthenium(II) chloride - Introduction
[1,3-Bis(2,4, et)](tricyclohexylphosphine)-(2-oxobenzylidene)ruthenium(II) chloride LatMet, also known as "LatMet", is a complex containing ruthenium metal. It has the following properties:
Nature:
1. appearance: colorless crystal or powder solid.
2. solubility: soluble in organic solvents such as chloroform, dichloromethane, insoluble in water.
3. melting point: about 150-160 ℃.
Use:
1. Catalyst: LatMet is widely used to catalyze organic synthesis reactions, especially hydrogenation, oxidation, methylation and olefin conversion reactions. It shows good catalytic activity and selectivity in asymmetric synthesis.
2. Medical applications: Some researchers have also explored LatMet's potential application in cancer treatment.
Preparation Method:
The preparation of LatMet is generally obtained by synthetic reaction, the specific steps are as follows:
1. First, 1,3-Bis(2,4, Ti) vanadium ruthenium (II) complex was synthesized.
2. Next, by reacting with sodium tricyclohexylphosphine, the ligand [1,3-Bis(2,4,)](tricyclohexylphosphine) is introduced.
3. Finally, the obtained complex is reacted with 2-oxobenzoyl sulfide sodium chloride to form [1,3-Bis(2,4, r)](tricyclohexylphosphine)-(2-oxobenzylidene)ruthenium(II) chloride LatMet.
Safety Information:
1. LatMet is a toxic substance that may cause harm to human health. When handling and using LatMet, necessary safety measures should be taken, such as wearing protective gloves, protecting eyes and respiratory tract, etc.
2. Avoid inhalation or contact with skin, and keep away from open flames and heat sources.
3. storage should be kept in a cool, dry and well-ventilated place, away from combustibles and oxidants.
Nature:
1. appearance: colorless crystal or powder solid.
2. solubility: soluble in organic solvents such as chloroform, dichloromethane, insoluble in water.
3. melting point: about 150-160 ℃.
Use:
1. Catalyst: LatMet is widely used to catalyze organic synthesis reactions, especially hydrogenation, oxidation, methylation and olefin conversion reactions. It shows good catalytic activity and selectivity in asymmetric synthesis.
2. Medical applications: Some researchers have also explored LatMet's potential application in cancer treatment.
Preparation Method:
The preparation of LatMet is generally obtained by synthetic reaction, the specific steps are as follows:
1. First, 1,3-Bis(2,4, Ti) vanadium ruthenium (II) complex was synthesized.
2. Next, by reacting with sodium tricyclohexylphosphine, the ligand [1,3-Bis(2,4,)](tricyclohexylphosphine) is introduced.
3. Finally, the obtained complex is reacted with 2-oxobenzoyl sulfide sodium chloride to form [1,3-Bis(2,4, r)](tricyclohexylphosphine)-(2-oxobenzylidene)ruthenium(II) chloride LatMet.
Safety Information:
1. LatMet is a toxic substance that may cause harm to human health. When handling and using LatMet, necessary safety measures should be taken, such as wearing protective gloves, protecting eyes and respiratory tract, etc.
2. Avoid inhalation or contact with skin, and keep away from open flames and heat sources.
3. storage should be kept in a cool, dry and well-ventilated place, away from combustibles and oxidants.
Last Update：2024-04-09 21:01:54
-(2-oxobenzylidene)ruthenium(II) chloride](http://res.chembk.com/assets/images/structure/1407229-58-6.gif)